- Home
- GDTC vs DRIO Comparison
GDTC vs DRIO Comparison
Compare GDTC & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- DRIO
- Stock Information
- Founded
- GDTC 2018
- DRIO 2011
- Country
- GDTC Singapore
- DRIO United States
- Employees
- GDTC N/A
- DRIO N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- DRIO Medical/Dental Instruments
- Sector
- GDTC Health Care
- DRIO Health Care
- Exchange
- GDTC Nasdaq
- DRIO Nasdaq
- Market Cap
- GDTC 21.5M
- DRIO 30.5M
- IPO Year
- GDTC 2023
- DRIO N/A
- Fundamental
- Price
- GDTC $1.89
- DRIO $0.58
- Analyst Decision
- GDTC Buy
- DRIO Strong Buy
- Analyst Count
- GDTC 1
- DRIO 2
- Target Price
- GDTC $5.00
- DRIO $2.50
- AVG Volume (30 Days)
- GDTC 18.1K
- DRIO 175.1K
- Earning Date
- GDTC 01-01-0001
- DRIO 08-11-2025
- Dividend Yield
- GDTC N/A
- DRIO N/A
- EPS Growth
- GDTC N/A
- DRIO N/A
- EPS
- GDTC N/A
- DRIO N/A
- Revenue
- GDTC $368,838.00
- DRIO $28,034,000.00
- Revenue This Year
- GDTC $5.37
- DRIO $20.85
- Revenue Next Year
- GDTC N/A
- DRIO $17.09
- P/E Ratio
- GDTC N/A
- DRIO N/A
- Revenue Growth
- GDTC N/A
- DRIO 47.20
- 52 Week Low
- GDTC $1.20
- DRIO $0.50
- 52 Week High
- GDTC $4.05
- DRIO $1.55
- Technical
- Relative Strength Index (RSI)
- GDTC 37.08
- DRIO 31.86
- Support Level
- GDTC $1.85
- DRIO $0.52
- Resistance Level
- GDTC $1.95
- DRIO $0.74
- Average True Range (ATR)
- GDTC 0.10
- DRIO 0.05
- MACD
- GDTC -0.02
- DRIO -0.02
- Stochastic Oscillator
- GDTC 28.00
- DRIO 26.48
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.